Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Leucémies aiguës
- Tout cancer hématologique
- | Specialty :
- Thérapies Ciblées
Extract
Phase II trial with safety-run-in of MEK inhibitor AS703026 in subjects with poor prognosis acute myeloid leukemia and other hematological malignancies.
Scientific Abstract
en cours d'intégration;